Dale A. Smith Memorial Award

This award, created in 2002 and funded by Fenwal, A Fresenius Kabi Company, honors Dale A. Smith, a long-time Baxter Healthcare executive who was responsible for establishing the Fenwal Division of Baxter. This award will be presented to an individual(s) or institution to recognize groundbreaking work performed in the application of technology to the practice of transfusion medicine or biotherapies.

The recipient(s) will receive an honorarium totaling $7,500. The Dale A. Smith Memorial Award is presented annually.

Eligibility

To be eligible for this award, candidates:

• Need not be a member of AABB
• Must demonstrate innovation and creativity in the application of technology for improving transfusion.
• Must have a completed nomination form submitted during the nomination period.

Selection

Recipient is selected by the National Blood Foundation (NBF) Scientific Grants Review Committee with formal approval by the NBF Board of Trustees.

Please send all inquiries about this award to awards@aabb.org.

2021 Recipients

Michael Pandelakis
Founder & CEO, BloodHub

Andrew Pandelakis
Founder & COO, BloodHub

Citation:

For introducing technology that allows electronic unit ordering and reference lab testing, greatly reducing the time and effort that blood suppliers and hospital customers spend on blood ordering, inventory management, logistics and billing. The initial BloodHub web application automated blood orders and managed inventory and was adaptable to a variety of computer systems. BloodHub technology evolved to take on reference lab testing requests (with automatic notification of workup status and electronic reporting), hospital product delivery and return transactions, transfers, discards, credits, and a complete unit audit trail, and, later, to include logistics, transportation, dispatchers, drivers, and route optimization. To complete the order-to-cash cycle, BloodHub created BloodBill which today generates invoices totalling $1 billion annually. BloodHub serves 50,000 users at more than 4,000 hospitals who place 1.8 million orders for nearly 12 million components each year, representing approximately 65% of the transfusable units in the U.S.

View All Recipients